I, and I am sure others, will be interested in hearing of your experiences with Padcev. So many new trials for the evolving MABs sound good but need to move to later stage trials. I look forward to learning from the experiences of others, always remembering that we each react differently to drugs; that each of us has a different history and health status.
I attempted to enter the Padcev study, but was rejected because I have two concurrent flavors of cancer. That was not acceptable to a trial that aimed to address ONE type of cancer only. Padvec looked good - worth a try - to me & primary care team.
Fortunately, Keytruda went to open status for advanced cancer after platinum based chemo, and I opted in.
While a number of people here, and patients I have met, report positive results with Keytruda, the side effect hit me hard enough that I had to stop after 5 cycles. Obviously not the right drug for me.
Wishing you well with Padcev, please do keep us posted.